A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.

Karami E, Sabatier JM, Behdani M, Irani S, Kazemi-Lomedasht F

Open source

DOI
10.1080/14756366.2020.1758690
Published
2020 Dec
Container
Journal of enzyme inhibition and medicinal chemistry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14756366.2020.1758690,
  title = {A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.},
  author = {Karami E and Sabatier JM and Behdani M and Irani S and Kazemi-Lomedasht F},
  year = {2020},
  journal = {Journal of enzyme inhibition and medicinal chemistry},
  doi = {10.1080/14756366.2020.1758690},
  url = {https://doi.org/10.1080/14756366.2020.1758690}
}

RIS

TY  - JOUR
TI  - A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.
AU  - Karami E
AU  - Sabatier JM
AU  - Behdani M
AU  - Irani S
AU  - Kazemi-Lomedasht F
PY  - 2020
JO  - Journal of enzyme inhibition and medicinal chemistry
DO  - 10.1080/14756366.2020.1758690
UR  - https://doi.org/10.1080/14756366.2020.1758690
ER  - 

APA

E, K., JM, S., M, B., S, I., & F, K. (2020). A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis.. Journal of enzyme inhibition and medicinal chemistry. https://doi.org/10.1080/14756366.2020.1758690

Source records